Doing it our way now: the approach this company pioneered is becoming the market's way
The model's full reasoning — Q3 2023 call → NOWe need to determine if management describes that their way of doing things is being adopted, copied, or moved toward by others in the market. The transcript mentions independent studies conducted by doctors using ProSense, and that these studies are being presented at conferences. Management says: "We had some significant achievement on the regulatory front... Additionally, we encourage with the vast number of independent studies being initiated, conducted, and published by doctors using ProSense." And later: "As independent user data continues to grow and is shared at medical conference and in journals, this is creating a growing momentum as more and more doctors and patients become aware of ProSense as a minimally invasive option. We believe the independent study data is a major catalyst for ProSense adoption." This indicates that doctors are using ProSense and conducting studies, which is a form of adoption. But is it that others are copying the company's approach? The company's approach is cryoablation for breast cancer and other indications. The independent studies are by doctors using ProSense, so they are using the company's product. That is not necessarily "others adopting the company's way" in the sense of competitors or new entrants following. It's more about clinical adoption. The question asks: "does management describe that the WAY THIS COMPANY DOES THINGS — an approach, product design, technology, method, business model, or way of serving customers that the company pioneered, built, or is identified with — is NOW BEING ADOPTED, COPIED, OR MOVED TOWARD BY OTHERS IN ITS MARKET?" The independent studies are by doctors using the product, not by competitors or other companies. There is no mention of competitors copying the technology or approach. Management does not say that others are following their lead in terms of the industry. They talk about growing awareness and adoption, but that is not the same as others imitating the company's way. The question specifically asks about "others" in the market, meaning competitors or new entrants. The transcript does not mention any competitors or other companies adopting the cryoablation approach. It only mentions doctors using ProSense. So that is not the phenomenon described. Also, management does not treat it as validation of being ahead in the sense of competitors following.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| TGT | Target Corporation | Q4 2022 | 2023-02-28 | C |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| USFD | US Foods Holding Corp. | Q1 2018 | 2018-05-12 | C |
| SHOO | Steven Madden, Ltd. | Q1 2017 | 2017-04-21 | C |
AES · Q1 2024 → YESThe question is: Does management describe that the WAY THIS COMPANY DOES THINGS is NOW BEING ADOPTED, COPIED, OR MOVED TOWARD BY OTHERS IN ITS MARKET, so that the company's own way of doing things is ...
GGR · Q1 2023 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?
TGT · Q4 2022 → YESThe question is: Does management describe that the way this company does things is now being adopted, copied, or moved toward by others in its market?